Cytokinetic and biochemical effects of sangivamycin in human colon carcinoma cells in culture.
D000903:Antibiotics, Antineoplastic / Q000494:pharmacology*; D002455:Cell Division / Q000187:drug effects; D002478:Cells, Cultured; D003110:Colonic Neoplasms / Q000378:metabolism* / Q000473:pathology; D004273:DNA, Neoplasm / Q000096:biosynthesis; D006801:Humans; D009374:Neoplasms, Experimental / Q000378:metabolism / Q000473:pathology; D011741:Pyrimidine Nucleosides / Q000494:pharmacology*; D012334:RNA, Neoplasm / Q000096:biosynthesis; D013997:Time Factors
D000903:Antibiotics, Antineoplastic; D004273:DNA, Neoplasm; D011741:Pyrimidine Nucleosides; D012334:RNA, Neoplasm; C005699:sangivamycin